V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010258 | 270006009 | 1.75 | 66 | Palliative (P) | 2015-09-23 | 2015-09-23 | Cladribine + Rituximab | N | N | 270023981 | FLUOROURACIL + RT |
| 270010259 | 270006010 | 1.73 | null | null | 2014-01-21 | 2014-01-22 | CHOP | N | null | 270023993 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270010260 | 270006011 | 1.6 | 81.7 | Curative (C) | null | 2014-05-16 | CISPLATIN + ETOPOSIDE | null | null | 270023994 | ABVD R |
| 270010261 | 270006011 | 1.6 | 68.9 | Curative (C) | 2017-07-26 | 2017-07-30 | CAPECITABINE + IRINOTECAN | 02 | N | 270023994 | CVP R |
| 270010262 | 270016099 | 1.79 | null | Not known (9) | 2015-06-16 | 2015-07-01 | R ABVD | N | N | 270024011 | CAPECITABINE + IRINOTECAN |
| 270010263 | 270006012 | 1.65 | 73.1 | Palliative (P) | 2015-06-02 | 2015-06-25 | R ABVD | N | N | 270024022 | CVP R |
| 270010264 | 270006013 | 1.68 | 67 | Curative (C) | 2014-10-18 | 2014-10-20 | Rituximab (Maintenance) | Y | N | 270024025 | CHOP |
| 270010265 | 270006013 | 1.82 | 89.9 | Palliative (P) | 2016-03-27 | 2016-04-02 | CVP R | N | N | 270024025 | NOT MATCHED |
| 270010266 | 270016100 | 1.76 | 57 | Curative (C) | 2015-05-15 | 2015-05-22 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | N | N | 270024030 | CVP |
| 270010267 | 270016100 | 1.75 | 119.4 | Curative (C) | 2016-09-17 | 2016-09-17 | IGEV | N | N | 270024030 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010268 | 270006014 | 1.73 | 77 | Disease modification (D) | 2015-05-09 | 2015-05-13 | IBRUTINIB | 02 | N | 270024034 | LOPP |
| 270010269 | 270006014 | 1.59 | 61.5 | Disease modification (D) | 2013-03-25 | 2013-03-26 | CVP R | 2 | N | 270024034 | CISPLATIN + GEMCITABINE |
| 270010270 | 270006014 | 1.67 | 42.7 | Palliative (P) | 2016-09-08 | 2016-09-10 | CHOP - 21 days | 02 | N | 270024034 | IVE |
| 270010271 | 270006014 | 1.57 | 63.4 | Curative (C) | 2016-10-16 | 2016-10-28 | CVP R | Y | N | 270024034 | ABVD R |
| 270010272 | 270018909 | null | null | Curative (C) | 2015-05-28 | 2015-06-02 | CAPECITABINE + IRINOTECAN | N | null | 270024062 | DOCETAXEL |
| 270010274 | 270006015 | 1.76 | 25.6 | Adjuvant (A) | 2017-11-19 | 2017-11-30 | Cisplatin + Fluorouracil + RT 5day | N | N | 270024073 | CETUXIMAB + IRINOTECAN + MDG |
| 270010275 | 270006016 | 1.54 | 72 | null | 2014-12-11 | 2015-01-02 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 2 | N | 270024077 | CHOP |
| 270010276 | 270006016 | 1.87 | 65.4 | Curative (C) | 2015-02-25 | 2015-03-11 | CETUXIMAB + RT | N | N | 270024077 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270010277 | 270006016 | 1.75 | 0 | Curative (C) | 2016-01-11 | 2016-01-18 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270024077 | LENALIDOMIDE |
| 270010278 | 270006017 | 0 | 55.3 | Curative (C) | 2015-03-27 | 2015-03-29 | R ABVD | 02 | N | 270024094 | ABVD R |
| 270010279 | 270012973 | 1.75 | 79.8 | Disease modification (D) | 2016-02-10 | 2016-02-16 | Bevacizumab 5mg/kg | N | N | 270024095 | VINBLASTINE |
| 270010280 | 270012973 | 1.59 | 113.8 | Curative (C) | 2017-06-08 | 2017-06-16 | CVP R | N | N | 270024095 | LENALIDOMIDE |
| 270010281 | 270006018 | 1.75 | 73.6 | null | 2015-07-12 | 2015-07-13 | ESHAP | N | N | 270024105 | PMITCEBO |
| 270010282 | 270006019 | 1.8 | 130.8 | Not known (9) | 2019-03-27 | 2019-04-04 | Bendamustine+Rituximab(Sub Courses) | N | N | 270024111 | NOT MATCHED |
| 270010283 | 270006020 | 1.61 | 76 | Adjuvant (A) | 2015-04-20 | 2015-05-19 | Carboplatin AUC 6 - 10 | N | N | 270024115 | ABVD R |
| 270010284 | 270006021 | 1.69 | 83.7 | Curative (C) | 2016-05-09 | 2016-06-09 | FLAG | 02 | N | 270024122 | BEAM + FLUDARABINE |
| 270010285 | 270006021 | 1.74 | null | Curative (C) | null | 2014-01-15 | CVP R | null | null | 270024122 | ABVD R |
| 270010286 | 270016104 | null | 77 | Curative (C) | 2016-08-26 | 2016-08-28 | GEMCITABINE + VINORELBINE | N | null | 270024131 | BRENTUXIMAB |
| 270010287 | 270006022 | 1.67 | 96 | Disease modification (D) | 2017-11-12 | 2017-11-17 | CVP R | N | N | 270024144 | CHOP |
| 270010288 | 270012975 | 1.83 | 39.4 | Neo-adjuvant (N) | 2014-04-08 | 2014-04-08 | Dacarbazine | N | null | 270024149 | GEMCITABINE + VINORELBINE |
| 270010289 | 270016105 | 1.64 | 85 | Curative (C) | 2015-03-07 | 2015-03-11 | DHAP | 2 | N | 270024151 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010290 | 270016105 | 1.86 | 74 | null | 2015-06-21 | 2015-06-25 | ChIVPP/EVA | 02 | Y | 270024151 | CETUXIMAB |
| 270010292 | 270006023 | 1.77 | 61 | null | 2013-11-08 | 2013-11-22 | Docetaxel 75mg/m2 (21 day) | Y | null | 270024176 | CAPECITABINE + IRINOTECAN |
| 270010293 | 270006024 | 1.54 | 51.1 | Palliative (P) | 2013-12-30 | 2014-01-01 | Brentuximab | 02 | N | 270024177 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270010294 | 270006025 | 1.68 | 56.2 | Curative (C) | 2012-12-20 | 2013-01-04 | CVP R | N | N | 270024185 | LOPP |
| 270010295 | 270006026 | 1.65 | 61.1 | Curative (C) | 2018-04-16 | 2018-04-17 | ECHELON 1 TRIAL | 02 | N | 270024186 | ESHAP |
| 270010296 | 270006027 | 1.67 | 43.5 | Palliative (P) | 2015-08-24 | 2015-08-31 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 270024192 | LOPP |
| 270010297 | 270006028 | 1.64 | 72 | Palliative (P) | 2014-06-05 | 2014-06-09 | CVP R | Y | N | 270024194 | ENZALUTAMIDE |
| 270010298 | 270006029 | 1.64 | 68 | Curative (C) | 2016-03-09 | 2017-07-06 | Vinblastine | Y | null | 270024204 | NOT MATCHED |
| 270010299 | 270006030 | 1.54 | 95.2 | Palliative (P) | 2016-11-25 | 2016-12-09 | MELPHALAN + RITUXIMAB | Y | N | 270024213 | ABVD R |
| 270010300 | 270006030 | 1.6 | null | Curative (C) | null | 2016-02-02 | Vinblastine | null | null | 270024213 | GEMCITABINE + OXALIPLATIN |
| 270010301 | 270006031 | 1.69 | 64 | null | 2016-04-13 | 2016-04-13 | CVP R | 02 | N | 270024219 | ABVD R |
| 270010302 | 270012977 | null | null | null | 2018-05-18 | 2018-05-18 | BEAM | 02 | N | 270024235 | CVP R |
| 270010303 | 270006032 | 1.69 | null | Palliative (P) | 2016-12-02 | 2016-12-03 | BENDAMUSTINE + RITUXIMAB | 02 | N | 270024239 | RITUXIMAB |
| 270010304 | 270006033 | 1.73 | 81.6 | Curative (C) | 2014-07-07 | 2014-07-08 | R ABVD | 02 | N | 270024240 | VINBLASTINE |
| 270010306 | 270006035 | 1.59 | 80.9 | null | 2014-10-31 | 2014-11-20 | Carboplatin AUC 6 - 10 | 2 | N | 270024245 | CISPLATIN + ETOPOSIDE |
| 270010307 | 270006036 | 1.69 | null | Disease modification (D) | 2014-07-06 | 2014-07-23 | null | N | N | 270024247 | IVE |
| 270010308 | 270012978 | 1.56 | 89 | null | 2015-08-26 | 2015-09-09 | CCEP | N | N | 270024266 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270010309 | 270012978 | 1.7 | 87 | Curative (C) | 2017-01-17 | 2017-01-28 | null | 02 | N | 270024266 | CVP R |
| 270010310 | 270006037 | 1.65 | 137.2 | null | 2015-06-14 | 2015-06-14 | null | N | null | 270024272 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |